News & Events
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
Mirati Therapeutics, in collaboration with Array BioPharma (Pfizer) and Monoceros Biosystems, published a novel Nature Medicine article entitled "Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor" Read Article
The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Mirati Therapeutics, in collaboration with additional groups including Monoceros Biosystems, published a novel Cancer Discovery article entitled “The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients” Read Article
Monoceros Biosystems: Bringing Professional Grade Bioinformatics to All
Monoceros Biosystems has been selected as a top 10 bioinformatics solution provider for 2019 by the CIO Applications magazine. The Moniker of the Unicorn–the mythical, single-homed creature–is typically bestowed upon an individual or entity that excels at multiple crafts. Stands to reason that Monoceros Biosystems-the bioinformatics solutions provider that brings top-flight analyses to small companies at affordable costs– named itself Monoceros, which is Greek for unicorn. Headquartered in San Diego, [...]
Monoceros Biosystems, a top bioinformatics/computational biology industry partner, is pleased to announce the appointment of John Lamb, PhD and Dan Rawlins, JD to its Advisory Board
Monoceros Biosystems LLC is pleased to announce that John Lamb, PhD and Dan Rawlins, JD joined its Advisory Board. “As we pursue our goal of building the top value added Bioinformatics company, I couldn’t be more excited to have John and Dan join our emerging advisory board. John brings tremendous experience in computational biology and drug discovery industry and Dan brings top grade legal and compliance standards” said Adam Pavlicek, [...]